{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:33:52Z","timestamp":1764174832224,"version":"3.41.2"},"reference-count":98,"publisher":"FapUNIFESP (SciELO)","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Acad. Bras. Ci\u00eanc."],"DOI":"10.1590\/0001-3765202020200466","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T14:04:02Z","timestamp":1591970642000},"source":"Crossref","is-referenced-by-count":11,"title":["COVID-19: therapeutic approaches description and discussion"],"prefix":"10.1590","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3657-8368","authenticated-orcid":false,"given":"GUILHERME G.","family":"TRINDADE","sequence":"first","affiliation":[{"name":"University of Bras\u00edlia,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4266-2964","authenticated-orcid":false,"given":"SAMYRA M.C.","family":"CAXITO","sequence":"additional","affiliation":[{"name":"AMIL\/United Health Group (UHG),  Brazil; Institute of Management and Health of the Federal District (IGES-DF),  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8558-4196","authenticated-orcid":false,"given":"ALESSANDRA REJANE E.O.","family":"XAVIER","sequence":"additional","affiliation":[{"name":"State University of Montes Claros,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0512-1616","authenticated-orcid":false,"given":"MAURO A.S.","family":"XAVIER","sequence":"additional","affiliation":[{"name":"State University of Montes Claros,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8358-8062","authenticated-orcid":false,"given":"FABIANA","family":"BRAND\u00c3O","sequence":"additional","affiliation":[{"name":"University of Bras\u00edlia,  Brazil; University of Bras\u00edlia,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2020]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease","volume":"9","author":"AGOSTINI ML","year":"2018","journal-title":"MBio"},{"key":"ref2","article-title":"The novel coronavirus disease (COVID-19) outbreak trends in mainland China: A joinpoint regression analysis of the outbreak data from January 10 to February 11","author":"AL HASAN SM","year":"2020","journal-title":"Bull World Health Organ"},{"year":"2020","series-title":"Nota T\u00e9cnica sobre Cloroquina e Hidroxicloroquina","key":"ref3"},{"year":"2020","series-title":"Covid-19: Liberada pesquisa com hidroxicloroquina\u2014Not\u00edcias","author":"ANVISA -","key":"ref4"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"ANDERSEN KG","year":"2020","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30567-5","article-title":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?","author":"ANDERSON RM","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092336","article-title":"Flavivirus Replication Organelle Biogenesis in the Endoplasmic Reticulum: Comparison with Other Single-Stranded Positive-Sense RNA Viruses","volume":"20","author":"ARAKAWA M","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref8","series-title":"Meyler\u2019s Side Effects of Drugs","first-page":"253","volume-title":"Chloroquine and hydroxychloroquine","author":"ARONSON JK","year":"2016"},{"year":"2020","series-title":"What Will be the Economic Impact of COVID-19? Rough Estimates of Disease Scenarios","author":"ATKESON AG","key":"ref9"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds","volume":"115","author":"B\u00c1EZ-SANTOS YM","year":"2015","journal-title":"Antiviral Res"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","article-title":"Hydroxychloroquine: From malaria to autoimmunity","volume":"42","author":"BEN-ZVI I","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref12","article-title":"Structure of the Thermus thermophilus 70S ribosome complexed with azithromycin","author":"BULKLEY DP","year":"2010","journal-title":"RCSB PDB"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19","volume":"382","author":"CAO ET","year":"2020","journal-title":"N Engl J Med"},{"year":"2020","series-title":"Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19)","key":"ref14"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcv.2004.03.003","article-title":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds","volume":"31","author":"CHEN F","year":"2004","journal-title":"J Clin Virol"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"CHU CM","year":"2004","journal-title":"Thorax"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","volume":"55","author":"COLSON P","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"ref18","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","author":"CORTEGIANI A","year":"2020","journal-title":"J Crit Care"},{"issue":"22","key":"ref19","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/asia.201900841","article-title":"New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections","volume":"14","author":"DE CLERCQ E","year":"2019","journal-title":"Chem Asian J"},{"year":"2020","series-title":"Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand","author":"FERGUSON NM","key":"ref20"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"FURUTA Y","year":"2013","journal-title":"Antiviral Res"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"FURUTA Y","year":"2017","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"GAO J","year":"2020","journal-title":"Biosci Trends"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial","author":"GAUTRET ET","year":"2020","journal-title":"Int J Antimicrob Agent"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19","author":"GELERIS J","year":"2020","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"GORBALENYA AE","year":"2020","journal-title":"Nat Microbiol"},{"key":"ref27","article-title":"Compassionate Use of Remdesivir for Patients with Severe Covid-19","author":"GREIN J","year":"2020","journal-title":"N Engl J Med"},{"year":"2005","series-title":"As bases farmacol\u00f3gicas da terap\u00eautica","author":"HARDMAN JG","key":"ref28"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"HOFFMANN M","year":"2020","journal-title":"Cell"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00754-20","article-title":"Nafamostat mesylate blocks activation of SARS-CoV-2: New treatment option for COVID-19","volume":"64","author":"HOFFMANN M","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"5332","key":"ref31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/235050a0","article-title":"Lysosomes, pH and the anti-malarial action of chloroquine","volume":"235","author":"HOMEWOOD CA","year":"1972","journal-title":"Nature"},{"issue":"10223","key":"ref32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"HUANG C","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ccm.2016.11.008","article-title":"Antiviral Treatments","volume":"38","author":"ISON MG","year":"2017","journal-title":"Clin Chest Med"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104874","article-title":"Nitazoxanide\/azithromycin combination for COVID-19: A suggested new protocol for early management","volume":"157","author":"KELLENI MT","year":"2020","journal-title":"Pharmacol Res"},{"key":"ref35","article-title":"Genomic characterization of a novel SARS-CoV-2","author":"KHAILANY RA","year":"2020","journal-title":"Gene Rep"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1124\/dmd.110.037523","article-title":"Complex drug interactions of HIV protease inhibitors 1: Inactivation, induction, and inhibition of cytochrome P450 3A by ritonavir or nelfinavir","volume":"39","author":"KIRBY BJ","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"4831","key":"ref37","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.3317830","article-title":"Efflux of chloroquine from Plasmodium falciparum: Mechanism of chloroquine resistance","volume":"238","author":"KROGSTAD DJ","year":"1987","journal-title":"Science"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4269\/ajtmh.1987.36.213","article-title":"The basis of antimalarial action: Non-weak base effects of chloroquine on acid vesicle pH","volume":"36","author":"KROGSTAD DJ","year":"1987","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/03009747409115809","article-title":"Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine","volume":"3","author":"LAAKSONEN AL","year":"1974","journal-title":"Scand J Rheumatol"},{"issue":"5742","key":"ref40","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"LI F","year":"2005","journal-title":"Science"},{"issue":"1","key":"ref41","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"LIU J","year":"2020","journal-title":"Cell Discovery"},{"issue":"10224","key":"ref42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding","volume":"395","author":"LU R","year":"2020","journal-title":"Lancet"},{"key":"ref43","first-page":"95","article-title":"HIV protease inhibitors: A review of molecular selectivity and toxicity","volume":"7","author":"LV Z","year":"2015","journal-title":"HIV AIDS"},{"volume-title":"Evaluation of Ebola Virus Inhibitors for Drug Repurposing","series-title":"ACS Infectious Diseases","author":"MADRID PB","key":"ref44"},{"key":"ref45","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00399-20","article-title":"Compounds with therapeutic potential against novel respiratory 2019 coronavirus","author":"MARTINEZ MA","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"1A","key":"ref46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(83)91265-2","article-title":"Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate","volume":"75","author":"MCCHESNEY EW","year":"1983","journal-title":"Am J Med"},{"issue":"10229","key":"ref47","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"MEHTA P","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/13543784.2016.1212837","article-title":"Investigational protease inhibitors as antiretroviral therapies","volume":"25","author":"MIDDE NM","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","DOI":"10.22354\/in.v24i3.848","article-title":"A new emerging zoonotic virus of concern: The 2019 novel Coronavirus (COVID-19)","volume":"24","author":"MILL\u00c1N-O\u00d1ATE J","year":"2020","journal-title":"Infectio"},{"issue":"11","key":"ref50","doi-asserted-by":"crossref","DOI":"10.1097\/00002030-199811000-00001","article-title":"Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients","volume":"12","author":"MITSUYASU ET","year":"1998","journal-title":"AIDS"},{"key":"ref51","series-title":"Molecular Virology","first-page":"185","volume-title":"Viruses with Single-Stranded, Positive-Sense RNA Genomes","author":"MODROW S","year":"2013"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmal.2020.03.006","article-title":"No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection","volume":"50","author":"MOLINA JM","year":"2020","journal-title":"Med Mal Infect"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrmicro2692","article-title":"The dependence of viral RNA replication on co-opted host factors","volume":"10","author":"NAGY PD","year":"2011","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jmv.10499","article-title":"Early events of SARS coronavirus infection in vero cells","volume":"71","author":"NG ML","year":"2003","journal-title":"J Med Virol"},{"year":"2020","series-title":"Adaptive COVID-19 Treatment Trial (ACTT)\u2014ClinicalTrials.gov","key":"ref55"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"OESTEREICH L","year":"2014","journal-title":"Antiviral Res"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/art.1780390122","article-title":"The antiinflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis","volume":"39","author":"ORNSTEIN MH","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5501\/wjv.v2.i2.32","article-title":"Architecture and biogenesis of plus-strand RNA virus replication factories","volume":"2","author":"PAUL D","year":"2013","journal-title":"World J Virol"},{"issue":"5","key":"ref59","article-title":"Azithromycin a review of its antimicrobial activity, pharmacokinetic properties and clinical efficiency","volume":"44","author":"PERTER DH","year":"1992","journal-title":"Drugs"},{"issue":"3","key":"ref60","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/v1031209","article-title":"Current and Novel Inhibitors of HIV Protease","volume":"1","author":"POKORN\u00c1 J","year":"2009","journal-title":"Viruses"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/15.3.235","article-title":"Chloroquine: A review","volume":"15","author":"POPERT AJ","year":"1976","journal-title":"Rheumatol Rehabil"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1165\/rcmb.2012-0339OC","article-title":"Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus","volume":"48","author":"QIAN Z","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"ref63","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jmv.20095","article-title":"The life cycle of SARS coronavirus in Vero E6 cells","volume":"73","author":"QINFEN Z","year":"2004","journal-title":"J Med Virol"},{"issue":"5","key":"ref64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","volume":"23","author":"RAINSFORD KD","year":"2015","journal-title":"Inflammopharmacology"},{"key":"ref65","series-title":"Rang & Dale\u2019s Pharmacology","volume-title":"Antiprotozoal drugs","author":"RANG HP","year":"2007"},{"key":"ref66","series-title":"Viruses","volume-title":"The Virus-Host Interplay: Biogenesis of RNA Replication Complexes","author":"REID C","year":"2015"},{"issue":"50","key":"ref67","doi-asserted-by":"crossref","first-page":"14408","DOI":"10.1073\/pnas.1618029113","article-title":"Zika virus cell tropism in the developing human brain and inhibition by azithromycin","volume":"113","author":"RETALLACK H","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref68","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.3390\/v6072826","article-title":"Membranous replication factories induced by plus-strand RNA viruses","volume":"6","author":"ROMERO-BREY I","year":"2014","journal-title":"Viruses"},{"issue":"6","key":"ref69","doi-asserted-by":"crossref","DOI":"10.3390\/v8060160","article-title":"Endoplasmic Reticulum: The Favorite Intracellular Niche for Viral Replication and Assembly","volume":"8","author":"ROMERO-BREY I","year":"2016","journal-title":"Viruses"},{"key":"ref70","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.8630","article-title":"Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State","author":"ROSENBERG ES","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"ref71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jiph.2016.04.001","article-title":"Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus","volume":"9","author":"ROSSIGNOL J-F","year":"2016","journal-title":"J Infect Public Health"},{"year":"2020","series-title":"Economic Waves: The Effect of the Wuhan COVID-19 on the World Economy (2019-2020)","author":"RUIZ ESTRADA M","key":"ref72"},{"issue":"18","key":"ref73","first-page":"1824","article-title":"Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)","volume":"323","author":"SANDERS JM","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"ref74","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(06)70361-9","article-title":"New insights into the antiviral effects of chloroquine","volume":"6","author":"SAVARINO A","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"ref75","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: Implications for rheumatology","volume":"16","author":"SCHREZENMEIER E","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"396","key":"ref76","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"SHEAHAN ET","year":"2017","journal-title":"Sci Transl Med"},{"issue":"5","key":"ref77","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.jmedchem.6b01594","article-title":"Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses","volume":"60","author":"SIEGEL D","year":"2017","journal-title":"J Med Chem"},{"issue":"33","key":"ref78","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1073\/pnas.0505577102","article-title":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry","volume":"102","author":"SIMMONS G","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"SI-1","key":"ref79","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3906\/sag-2004-145","article-title":"Antiviral treatment of COVID-19","volume":"50","author":"\u015eIM\u015eEK YAVUZ","year":"2020","journal-title":"Turk J Med Sci"},{"year":"2020","series-title":"COVID-19 Drug Therapy - Potential Options. ELSEVIER, Clinical Drug Information, Clinical Solutions","author":"SMITH T","key":"ref80"},{"issue":"5","key":"ref81","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1590\/S1413-86702009000500012","article-title":"The Place of protease inhibitors in antiretroviral treatment","volume":"13","author":"TENORE SB","year":"2009","journal-title":"Braz J Infect Dis"},{"key":"ref82","article-title":"Crystal Structure Of Azithromycin Bound To The G2099A Mutant 50S Ribosomal Subunit Of Haloarcula Marismortui","author":"TU D","year":"2005","journal-title":"RCSB PDB"},{"issue":"1","key":"ref83","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"VINCENT MJ","year":"2005","journal-title":"Virol J"},{"issue":"11","key":"ref84","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01043-16","article-title":"Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay","volume":"60","author":"YAMAMOTO M","year":"2016","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"ref85","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/cr.2008.15","article-title":"SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway","volume":"18","author":"WANG H","year":"2008","journal-title":"Cell Res"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"WANG M","year":"2020","journal-title":"Cell Res"},{"issue":"7594","key":"ref87","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"WARREN TK","year":"2016","journal-title":"Nature"},{"issue":"6","key":"ref88","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/322858","article-title":"Chloroquine-resistant malaria","volume":"184","author":"WELLEMS TE","year":"2001","journal-title":"J Infect Dis"},{"year":"2020","series-title":"Naming the coronavirus disease (COVID-19) and the virus that causes it","key":"ref89"},{"year":"2020","series-title":"Pneumonia of unknown cause-China. Emergencies Preparedness, Response, Disease Outbreak News, World Health Organization (WHO)","key":"ref90"},{"issue":"27","key":"ref91","doi-asserted-by":"crossref","first-page":"10012","DOI":"10.1073\/pnas.0403596101","article-title":"Small molecules targeting severe acute respiratory syndrome human coronavirus","volume":"101","author":"WU C-Y","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"ref92","article-title":"Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV","volume":"12","author":"XU J","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"ref93","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"XU H","year":"2020","journal-title":"Int J Oral Sci"},{"year":"2020","series-title":"Potential Mechanisms of Age Related Severity of COVID-19 Infection: Implications for Vaccine Development and Convalescent Serum Therapy","author":"ZAND M","key":"ref94"},{"issue":"7798","key":"ref95","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"ZHOU P","year":"2020","journal-title":"Nature"},{"key":"ref96","article-title":"COVID-19: A recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","author":"ZHOU D","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"ref97","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"ZHU N","year":"2020","journal-title":"N Engl J Med"},{"issue":"Pt 4","key":"ref98","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/0022-1317-81-4-853","article-title":"Virus-encoded proteinases and proteolytic processing in the Nidovirales","volume":"81","author":"ZIEBUHR J","year":"2000","journal-title":"J Gen Virol"}],"container-title":["Anais da Academia Brasileira de Ci\u00eancias"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/aabc\/v92n2\/0001-3765-aabc-92-02-e20200466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T20:42:52Z","timestamp":1611434572000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0001-37652020000300902&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":98,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020]]}},"alternative-id":["S0001-37652020000300902"],"URL":"https:\/\/doi.org\/10.1590\/0001-3765202020200466","relation":{},"ISSN":["1678-2690","0001-3765"],"issn-type":[{"type":"electronic","value":"1678-2690"},{"type":"print","value":"0001-3765"}],"subject":[],"published":{"date-parts":[[2020]]},"article-number":"e20200466"}}